Cloud platform solution for easy and accurate quantitative assessment of brain images and for providing clinical decision support in neurological disorders.

Get support to manage the bulk of post COVID 19 patients being evaluated for dementia or Multiple Sclerosis

Up to 4 releases per Year

With cNeuro® you will be able to focus on essential information and automatically obtain a report that enables early diagnosis and efficient management of neurodegenerative diseases

Cloud

computing

Machine

learning

Web-

based

Patient

privacy

Collaborative Solution

cNeuro® cMRI 
Quantitative MRI for radiologists

  • Fully automated cross-sectional and longitudinal analysis of atrophy and lesions with seamless PACS integration.
  • Enhance your workflow and provide detailed report to referring physician.

cNeuro® cDSI 
 Advanced Solution for neurologists

  • Combines imaging findings with other data such as CSF-biomarkers and neuropsychology tests results and compares to a large database of previously diagnosed cases. 
  • Get support to detect disease early, perform differential diagnostics, predict progression and decide whether more testing is needed.

FOR MORE INFORMATION  
Please contact us at
Email: michel@combinostics.com
Phone: +32 497 319565 

OUR OFFICE
Combinostics Oy
Hatanpään valtatie 24
33100 Tampere, FINLAND

Go to article: Home | High-Tech Mental Health TreatmentsGo to article: In this issueGo to article: ContentsGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: PSN Labs Go to article: AccumoldGo to article: BriefingGo to article: Industry newsGo to article: Covid-19 executive briefing by GlobalDataGo to article: The medical industry briefingGo to article: uintent Company InsightGo to article: uintentGo to article: Apple RubberGo to article: Custom Wire Company Insight Go to article: Custom WireGo to article: CommentGo to article: Hearing implants market to reach $2.1bn by 2028, post-Covid-19Go to article: Recent hacks highlight importance of strong cybersecurityGo to article: Disposable endoscopes set to disrupt the reusable endoscopes marketGo to article: Will Covid-19 tests with EUA need to seek FDA approval once pandemic passes?Go to article: Covid-19 had a negative impact on general surgery device markets in 2020Go to article: Desert Platforms Company Insight Go to article: Desert PlatformsGo to article: CombinosticsGo to article: Duke Empirical Company Insight Go to article: Duke EmpiricalGo to article: In DepthGo to article: How can AI transform pneumonia diagnosis?Go to article: Using virtual reality to overcome anxious social avoidanceGo to article: Omar Ahmad: medtech’s quest for post-Covid success in 2021Go to article: NightWare vs nightmares: the sleep tech app helping break PTSD patternsGo to article: Just a swipe away: how the NHS plans to offer health records on iPhoneGo to article: Diagnostic imaging: assessing the testicular cancer riskGo to article: Do AI disease prediction models underestimate risk?Go to article: Will 2021 be just as challenging as 2020 for medtech notified bodies?Go to article: HirLan Company InsightGo to article: HirLanGo to article: Ergonomics FactoryGo to article: FISBAGo to article: In DataGo to article: Deals analysisGo to article: The medical industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issueGo to article: AxetrisGo to article: Smiths InterconnectGo to article: mdi ConsultantsGo to article: Omnica